论文部分内容阅读
目的观察重组人干扰素α-2b凝胶联合保妇康栓治疗宫颈糜烂的临床效果。方法选取该院2012年4月-2013年4月收治的宫颈糜烂患者216例,随机分为研究组与对照组,每组108例,研究组给予重组人干扰素α-2b凝胶与保妇康栓交替运用,对照组则单一给予保妇康栓治疗。对比2组总有效率和不良反应。结果研究组总有效率为95.37%高于对照组的83.33%,中、重度宫颈糜烂患者的总有效率均高于对照组,差异均有统计学意义(P<0.05)。结论重组人干扰素α-2b凝胶联合保妇康栓可使中、重度宫颈糜烂疗效提高,且安全性较高,值得临床推广应用。
Objective To observe the clinical effect of recombinant human interferon α-2b gel combined with Baofukang suppository for cervical erosion. Methods A total of 216 patients with cervical erosion who were admitted to our hospital from April 2012 to April 2013 were randomly divided into study group and control group with 108 cases in each group. The study group was given recombinant human interferon α-2b gel Kang bolt alternating use, the control group was given a single Bao Kangkang suppository treatment. The total effective rate and adverse reactions in two groups were compared. Results The total effective rate was 95.37% in the study group and 83.33% in the control group. The total effective rate in patients with moderate and severe cervical erosion was significantly higher than that in the control group (P <0.05). Conclusion Recombinant human interferon α-2b gel combined with Baofukang Suppository can improve the curative effect of moderate and severe cervical erosion and has high safety. It is worthy of clinical application.